You are here: Industry Insights > Covishield

News List

Striving to increase vaccine availability through imports: Govt expresspharma
July 09, 2021
MEA Spokesperson Arindam Bagchi said India hopes that individual countries would increasingly recognise made-in-India vaccines.
Covishield approval to be considered on receiving marketing authorisation application: EMA expresspharma
June 30, 2021
The Covishield vaccine “does not currently have a marketing authorisation” in Europe and the matter would be considered when an application is received for it, the European Medicines Agency (EMA) said.
Significant adverse effect unlikely with doses of different COVID-19 vaccines, but further scrutiny required: Govt expresspharma
May 31, 2021
Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is administered, but reaching a firm opinion on this will need more scrutiny and understanding, the Centre said.
Will be able to supply 9-10 crore doses of Covishield in June: SII expresspharma
May 31, 2021
In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 crore each in August and September.
More pharma companies should be permitted to produce COVID-19 vaccines: Gadkari expresspharma
May 19, 2021
Instead of one company, 10 more companies should be allowed to make vaccines by paying 10 per cent royalty to the original patent holder of the vaccine, he said.
Government to set up national platform to track and verify impact of COVID-19 vaccines expresspharma
May 17, 2021
The current data harmonisation work of ICMR and other agencies can be leveraged to set up this facility for review of ground realities on real-time basis, recommended NTAGI.
Over two billion doses of COVID-19 vaccines to be available between August to December 2021: Centre expresspharma
May 14, 2021
The Centre said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
NTAGI recommends gap of 12-16 weeks between doses of Covishield expresspharma
May 14, 2021
It has also suggested that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women can be inoculated any time after delivery.
Parliamentary panel had recommended ramping up vaccine manufacturing capacity in March expresspharma
May 13, 2021
The recommendations made by the 31-member committee that reportedly had as many as 14 members from the ruling BJP was tabled in Parliament on March 8.
SII endorses receiving Rs 1,732 crore for 11 crore doses of Covishield vaccine expresspharma
May 07, 2021
The company's response came after the Health Ministry in a statement refuted the allegations that it has not placed any fresh orders for the Covishield vaccine with SII.

Previous page 1 2 3 4 5 Next page